Lord, Abbett & Co’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Buy
+57,671
New +$11.1M 0.04% 345
2022
Q4
Sell
-477,065
Closed -$52.3M 576
2022
Q3
$52.3M Sell
477,065
-195,477
-29% -$24.8M 0.19% 146
2022
Q2
$88.9M Buy
+672,542
New +$88.2M 0.31% 87
2022
Q1
Sell
-15,237
Closed -$1.77M 607
2021
Q4
$1.77M Buy
15,237
+434
+3% +$51.1K ﹤0.01% 589
2021
Q3
$1.78M Sell
14,803
-82
-0.6% -$9.54K ﹤0.01% 619
2021
Q2
$1.78M Buy
14,885
+4,675
+46% +$513K ﹤0.01% 634
2021
Q1
$1.01M Sell
10,210
-679,440
-99% -$68.3M ﹤0.01% 620
2020
Q4
$69M Sell
689,650
-155,418
-18% -$16.5M 0.18% 178
2020
Q3
$92.6M Buy
845,068
+205,504
+32% +$22.9M 0.3% 103
2020
Q2
$67.7M Buy
639,564
+626,132
+4,661% +$64.7M 0.24% 123
2020
Q1
$1.2M Buy
+13,432
New +$1.26M 0.01% 607
2015
Q2
Sell
-44,897
Closed -$3.07M 923
2015
Q1
$3.07M Buy
44,897
+687
+2% +$47.7K 0.01% 805
2014
Q4
$3.11M Buy
44,210
+1,832
+4% +$131K 0.01% 807
2014
Q3
$3.03M Buy
+42,378
New +$3.1M 0.01% 829

Other funds holding AZN